BIOGEN INC. - COMMON STOCK

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

31 1月 2025 06:30:52 条件 Nasdaq GlobeNewswire

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

26 1月 2025 18:33:52 条件 Nasdaq GlobeNewswire

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

23 1月 2025 07:30:54 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

22 1月 2025 09:46:19 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 1月 2025 09:45:18 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 1月 2025 11:45:04 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

14 1月 2025 12:44:54 条件 NetDania Notify

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

13 1月 2025 19:05:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 12月 2024 09:45:32 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 12月 2024 09:59:02 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 12月 2024 15:07:02 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 12月 2024 09:45:54 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

13 12月 2024 09:49:29 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 11月 2024 09:45:06 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 11月 2024 09:45:08 条件 NetDania Notify

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

19 11月 2024 01:00:14 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 11月 2024 09:46:07 条件 NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 11月 2024 10:03:11 条件 NetDania Notify

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

14 11月 2024 11:23:15 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

14 11月 2024 09:45:06 条件 NetDania Notify